{
    "organizations": [],
    "uuid": "5cb01e657f240de17f765e5fd20fb4b94fac2057",
    "author": "",
    "url": "https://www.reuters.com/article/brief-solid-biosciences-provides-update/brief-solid-biosciences-provides-update-on-sgt-001-clinical-development-program-for-duchenne-muscular-dystrophy-idUSASC09W9E",
    "ord_in_thread": 0,
    "title": "BRIEF-Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 35 AM / Updated 23 minutes ago BRIEF-Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy Reuters Staff \n  Solid Biosciences Inc: \n* SOLID BIOSCIENCES PROVIDES UPDATE ON SGT-001 CLINICAL DEVELOPMENT PROGRAM FOR DUCHENNE MUSCULAR DYSTROPHY \n* SOLID BIOSCIENCES INC - FULL CLINICAL HOLD LETTER FROM FDA RECEIVED; COMPANY TO RESPOND IN COMING WEEKS \n* SOLID BIOSCIENCES INC - MANUFACTURING-RELATED PARTIAL CLINICAL HOLD ON HIGH DOSE OF SGT-001 RESOLVED \n* SOLID BIOSCIENCES - GOT LETTER FROM U.S. FDA RELATING TO PREVIOUSLY-ANNOUNCED FULL CLINICAL HOLD ON IGNITE DMD TRIAL \n* SOLID BIOSCIENCES - FULL CLINICAL HOLD WAS IN RESPONSE TO COâ€™S REPORT OF A SERIOUS ADVERSE EVENT IN FIRST PATIENT DOSED WITH SGT-001 IN IGNITE DMD \n* SOLID BIOSCIENCES - FDA SAYS CO ADDRESSED MANUFACTURING-RELATED QUESTIONS LEADING TO PARTIAL CLINICAL HOLD ON HIGH DOSE OF SGT-001 IN IGNITE DMD Source text for Eikon: Further company coverage:",
    "published": "2018-04-18T14:34:00.000+03:00",
    "crawled": "2018-04-18T15:00:25.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "bioscience",
        "provides",
        "update",
        "clinical",
        "development",
        "program",
        "duchenne",
        "muscular",
        "dystrophy",
        "reuters",
        "staff",
        "solid",
        "bioscience",
        "inc",
        "solid",
        "bioscience",
        "provides",
        "update",
        "clinical",
        "development",
        "program",
        "duchenne",
        "muscular",
        "dystrophy",
        "solid",
        "bioscience",
        "inc",
        "full",
        "clinical",
        "hold",
        "letter",
        "fda",
        "received",
        "company",
        "respond",
        "coming",
        "week",
        "solid",
        "bioscience",
        "inc",
        "partial",
        "clinical",
        "hold",
        "high",
        "dose",
        "resolved",
        "solid",
        "bioscience",
        "got",
        "letter",
        "fda",
        "relating",
        "full",
        "clinical",
        "hold",
        "ignite",
        "dmd",
        "trial",
        "solid",
        "bioscience",
        "full",
        "clinical",
        "hold",
        "response",
        "co",
        "report",
        "serious",
        "adverse",
        "event",
        "first",
        "patient",
        "dosed",
        "ignite",
        "dmd",
        "solid",
        "bioscience",
        "fda",
        "say",
        "co",
        "addressed",
        "question",
        "leading",
        "partial",
        "clinical",
        "hold",
        "high",
        "dose",
        "ignite",
        "dmd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}